Kristin B. Highland

Nintedanib for Systemic Sclerosis–Associated Interstitial Lung Disease

Oliver Distler, Kristin B. Highland, Martina Gahlemann et al. · New England Journal of Medicine · 2019 · 1.6K citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13

Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial

Donald P. Tashkin, Michael D. Roth, Philip J. Clements et al. · The Lancet Respiratory Medicine · 2016 · 1.1K citations

Medicine, Pharmacology, Pharmacotherapy +11

Efficacy and safety of nintedanib in patients with systemic sclerosis-associated interstitial lung disease treated with mycophenolate: a subgroup analysis of the SENSCIS trial

Kristin B. Highland, Oliver Distler, Masataka Kuwana et al. · The Lancet Respiratory Medicine · 2021 · 212 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +8

Safety, tolerability, and efficacy of pirfenidone in patients with rheumatoid arthritis-associated interstitial lung disease: a randomised, double-blind, placebo-controlled, phase 2 study

Joshua J. Solomon, Sonye K. Danoff, Felix Woodhead et al. · The Lancet Respiratory Medicine · 2022 · 208 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +8

Endothelial Fli1 Deficiency Impairs Vascular Homeostasis

Yoshihide Asano, Lukasz Stawski, Faye N. Hant et al. · American Journal Of Pathology · 2010 · 194 citations · Full text

Life Sciences, Genetics, Physiology +9